Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia

NCT02942602 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Atorvastatin 20 mg
DRUG: Cholestyramine 8 g
DRUG: Omega-3 2g
DRUG: Concurrent with Atorvastatin 5 mg + Ezetimibe 10 mg
BEHAVIORAL: Lifestyle modification

Sponsor

Yonsei University